Prime Medicine, Inc. (PRME) Earnings
|
Expand Research on PRME
| Next EPS Date | 10/30/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +21.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/26  |
Q326 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.24 | -$0.36 | +$0.12 | $1.15M | N/A | N/A |  | | Details | |
| 5/7/26 | Q126 | -$0.28 | -$0.36 | +$0.08 | $856K | N/A | N/A | | | Details | |
| 3/2/26 |
Q425 | N/A | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/27/26 |
Q425 | N/A | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q425 | N/A | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 | Q325 | -$0.32 | -$0.43 | +$0.11 | $1M | N/A | N/A | | | Details | |
| 11/5/25 |
Q325 | N/A | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A |
